ARTEMISMED SHARE PRICE PREDICTION
Recommendation → Expensive Star
- Week
- Month
- 3 Month
- Year
Open |
276.10
|
High |
283.50
|
Low |
276.10
|
52-Wk High |
304.70
|
52-Wk Low |
141.30
|
Interpretation of Candlestick Chart
Considering these factors, the current market outlook for ARTEMISMED suggests a challenging environment for buyers, with the potential for further downside movement in the short term.
ARTEMISMED Share price Prediction:-
Period | Target 1 | Target 2 |
---|---|---|
2024 | 142.71 | 304.72 |
2025 | 367.71 | 529.72 |
2026 | 592.71 | 754.72 |
2027 | 817.71 | 979.72 |
2028 | 1042.71 | 1204.72 |
2029 | 1267.71 | 1429.72 |
2030 | 1492.71 | 1654.72 |
2031 | 1717.71 | 1879.72 |
2032 | 1942.71 | 2104.72 |
2033 | 2167.71 | 2329.72 |
2034 | 2392.71 | 2554.72 |
ARTEMISMED share price target 2024 to 2034 :-
ARTEMISMED’s share price target is the estimated value of the stock at a given point in time. It is based on our research, history, fundamentals, market trends and other factors.
2024
The minimum share price target for ARTEMISMED shares is Rs 142.71 and the maximum
target
price is Rs 304.72 by 2024
- Target1 : 142.71
- Target 2 : 304.72
2025
The minimum share price target for ARTEMISMED shares is Rs 367.71 and the
maximum target price is Rs 529.72 by
2025
- Target1 : 367.71
- Target 2 : 529.72
2026
The minimum share price target for ARTEMISMED shares is Rs 592.71 and the
maximum target price is Rs 754.72 by
2026
- Target1 : 592.71
- Target 2 : 754.72
2027
The minimum share price target for ARTEMISMED shares is Rs 817.71 and the
maximum target price is Rs 979.72 by
2027
- Target1 : 817.71
- Target 2 : 979.72
2028
The minimum share price target for ARTEMISMED shares is Rs 1042.71 and the
maximum target price is Rs 1204.72 by
2028
- Target1 : 1042.71
- Target 2 : 1204.72
2029
The minimum share price target for ARTEMISMED shares is Rs 1267.71 and the
maximum target price is Rs 1429.72 by
2029
- Target1 : 1267.71
- Target 2 : 1429.72
2030
The minimum share price target for ARTEMISMED shares is Rs 1492.71 and the
maximum target price is Rs 1654.72 by
2030
- Target1 : 1492.71
- Target 2 : 1654.72
2031
The minimum share price target for ARTEMISMED shares is Rs 1717.71 and the
maximum target price is Rs 1879.72 by
2031
- Target1 : 1717.71
- Target 2 : 1879.72
2032
The minimum share price target for ARTEMISMED shares is Rs 1942.71 and the
maximum target price is Rs 2104.72 by
2032
- Target1 : 1942.71
- Target 2 : 2104.72
2033
The minimum share price target for ARTEMISMED shares is Rs 2167.71 and the
maximum target price is Rs 2329.72 by
2033
- Target1 : 2167.71
- Target 2 : 2329.72
2034
The minimum share price target for ARTEMISMED shares is Rs 2392.71 and the
maximum target price is Rs 2554.72 by
2034
- Target1 : 2392.71
- Target 2 : 2554.72
**ARTEMISMED share price target prediction for 2024, 2025, and 2026 through 2034 is based on growth assumptions, future forecasts, and the existing state of the market. It is subject to change dependent on market sentiment.
ARTEMISMED Past Performance:-
1 Day →
1 Week →
1 Month →
3 Month →
1 Year →
Simple Moving Average (SMA) of ARTEMISMED :-
SMA 5 → 272.29
SMA 34 → 279.10
SMA 20 → 273.12
SMA 13 → 276.73
SMA 89 → 277.61
SMA 200 → 211.71
Exponential Moving Average (EMA) of ARTEMISMED :-
EMA 5 → 274.16
EMA 34 → 274.05
EMA 20 → 275.17
EMA 13 → 274.60
EMA 89 → 269.53
EMA 200 → 220.46
Bollinger Band ARTEMISMED :-
BBand Upper → 289.35
BBand Lower → 256.90
BBand Mid → 273.12
Moving Average Convergence ARTEMISMED :-
MACD →
MACD Signal →
MACD Hist →
Past Performance
ARTEMISMED Change in 1 day
2.25%
Change in 1 day
ARTEMISMED Change in 1 Week
0.39%
Change in 1 Week
ARTEMISMED Change in 1 Month
-1.56%
Change in 1 Month
ARTEMISMED Change in 3 Month
7.38%
Change in 3 Month
ARTEMISMED Change in 1 Year
84.60%
Change in 1 Year
What is the current share price of ARTEMISMED ?
What is the target of ARTEMISMED tomorrow?
What is the full form of ARTEMISMED ?
Can I invest in ARTEMISMED share?
Is ARTEMISMED a buy hold or sell?
Durability : 1.11
Valuation : 0.14
Momentum : 85.83
Therefore, as per risk appetite of the investor whether to buy hold or sell the ARTEMISMED at current level.